These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 29283124)
1. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary? Chaugule SS; Park J; Finger PT Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes. Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia. Venkateswaran N; Mercado C; Galor A; Karp CL Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241 [TBL] [Abstract][Full Text] [Related]
4. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction. Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315 [TBL] [Abstract][Full Text] [Related]
6. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment. Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390 [TBL] [Abstract][Full Text] [Related]
7. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of topical 0.5% 5-Fluorouracil as primary treatment of ocular surface squamous neoplasia. Kato JM; Ballalai PL; de Lima PP; Santo RM Can J Ophthalmol; 2024 Oct; 59(5):e510-e514. PubMed ID: 38631493 [TBL] [Abstract][Full Text] [Related]
9. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Yeatts RP; Ford JG; Stanton CA; Reed JW Ophthalmology; 1995 Sep; 102(9):1338-44. PubMed ID: 9097771 [TBL] [Abstract][Full Text] [Related]
10. Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes. Agarwal A; Ghose N; Rathi V; Khanna R; Kaliki S BMC Ophthalmol; 2024 Sep; 24(1):389. PubMed ID: 39227791 [TBL] [Abstract][Full Text] [Related]
11. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]